PDG3 Comparison of Pharmacoeconomic Evaluation Guidelines in Korea, JAPAN and China

Abstract

Authors

M. Toumi A. Millier R. Han Y. Wang

Full Text Cite This Article
Back to Volume 22, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×